ThinkSabio

$PTGX

$145.94▲ +0.2% YTD

4 SEC 13D/G filings tracked · Last updated Sep 8, 2026

Filing History
News
PTGX ▲ +0.2% - Protagonist Therapeutics, Inc.
CP $145.94▲ +0.2%Sep 8, 2026 · ThinkSabio Blog

$PTGX - Protagonist Therapeutics Announces $300 Million Share Repurchase Program…

News
PTGX ▲ +0.1% - Protagonist Therapeutics, Inc.
CP $146.50▲ +0.1%Sep 2, 2026 · ThinkSabio Blog

$PTGX - Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026…

News
PTGX ▼ -2.3% - Protagonist Therapeutics, Inc.
CP $146.05▲ -2.3%Aug 29, 2026 · ThinkSabio Blog

$PTGX - Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera…

SEC 13D/G
PTGX - Protagonist Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified
$151.42▲ 73.65%Aug 13, 2026 · ThinkSabio Blog

$PTGX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PTGX Protagonist Therapeutics, Inc. : $151.42 Sector: Healthcar…